https://www.selleckchem.com/pr....oducts/ferrostatin-1
The patients who discontinued dapagliflozin use due to side effects comprised 49.7% (74/149). Two major side effects were genital tract infection in women (P less then .001 compared with men) and urinary tract infection, which increased with age (P = .03. Malpractice of medical personnel, insurance problems or causes of termination not related to dapagliflozin use comprised 14.1% (21/149). What is new and conclusion The incidence of side effects with dapagliflozin was not as high as expected. Physicians should consider instructi
Like
Comment
Share
